SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16467677
Source:
http://linkedlifedata.com/resource/pubmed/id/16467677
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0086418
,
umls-concept:C0205321
,
umls-concept:C0332237
,
umls-concept:C0536495
,
umls-concept:C0753645
,
umls-concept:C1522168
pubmed:issue
2
pubmed:dateCreated
2006-2-9
pubmed:abstractText
To determine the vitreous penetration of the new fourth-generation topical fluoroquinolones moxifloxacin 0.5% and gatifloxacin 0.3%.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8309919
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Aza Compounds
,
http://linkedlifedata.com/resource/pubmed/chemical/Fluoroquinolones
,
http://linkedlifedata.com/resource/pubmed/chemical/Ophthalmic Solutions
,
http://linkedlifedata.com/resource/pubmed/chemical/Quinolines
,
http://linkedlifedata.com/resource/pubmed/chemical/gatifloxacin
,
http://linkedlifedata.com/resource/pubmed/chemical/moxifloxacin
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0275-004X
pubmed:author
pubmed-author:BakriSophie JSJ
,
pubmed-author:BeerPaul MPM
,
pubmed-author:CostelloPatrickP
,
pubmed-author:FalkNaomi SNS
,
pubmed-author:MelendezJ AndreJA
,
pubmed-author:PetersGeorge BGB
,
pubmed-author:SinghRavinder JRJ
pubmed:issnType
Print
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
191-5
pubmed:dateRevised
2006-12-15
pubmed:meshHeading
pubmed-meshheading:16467677-Administration, Topical
,
pubmed-meshheading:16467677-Aged
,
pubmed-meshheading:16467677-Aged, 80 and over
,
pubmed-meshheading:16467677-Anti-Bacterial Agents
,
pubmed-meshheading:16467677-Aza Compounds
,
pubmed-meshheading:16467677-Biological Availability
,
pubmed-meshheading:16467677-Chromatography, High Pressure Liquid
,
pubmed-meshheading:16467677-Fluoroquinolones
,
pubmed-meshheading:16467677-Humans
,
pubmed-meshheading:16467677-Lens, Crystalline
,
pubmed-meshheading:16467677-Microbial Sensitivity Tests
,
pubmed-meshheading:16467677-Middle Aged
,
pubmed-meshheading:16467677-Ophthalmic Solutions
,
pubmed-meshheading:16467677-Prospective Studies
,
pubmed-meshheading:16467677-Pseudophakia
,
pubmed-meshheading:16467677-Quinolines
,
pubmed-meshheading:16467677-Retinal Diseases
,
pubmed-meshheading:16467677-Vitrectomy
,
pubmed-meshheading:16467677-Vitreous Body
,
pubmed-meshheading:16467677-Vitreous Hemorrhage
pubmed:year
2006
pubmed:articleTitle
Vitreous penetration of topical moxifloxacin and gatifloxacin in humans.
pubmed:affiliation
Lions Eye Institute, Albany Medical College, 35 Hackett Boulevard, Albany, NY 12208, USA.
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial